CRELUX
CRELUX conducts early-stage drug discovery research on behalf of clients in the pharmaceutical and biotechnology industries. We are part of WuXi AppTec, one of the world’s leading CRDMOs, with 28 sites and more than 40,000 employees worldwide. For many years, we have provided our partners with a broad range of research services in hit finding and lead optimization, including recombinant protein production, biophysical assays, medicinal chemistry, fragment screening, DEL screening, structural analysis of biomolecular targets as well as many biochemical and cellular functional assays. We are fully committed to realizing our vision that “every drug can be made and every disease can be treated.”
